ID   MPEG1_HUMAN             Reviewed;         716 AA.
AC   Q2M385; Q2M1T6; Q8TEF8;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 1.
DT   28-JUN-2023, entry version 119.
DE   RecName: Full=Macrophage-expressed gene 1 protein;
DE            Short=Macrophage gene 1 protein;
DE            Short=Mpg-1;
DE   AltName: Full=Perforin-2 {ECO:0000303|PubMed:23753625};
DE            Short=P-2 {ECO:0000303|PubMed:23753625};
DE   Flags: Precursor;
GN   Name=MPEG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-552.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=7888681;
RA   Spilsbury K., O'Mara M.-A., Wu W.M., Rowe P.B., Symonds G., Takayama Y.;
RT   "Isolation of a novel macrophage-specific gene by differential cDNA
RT   analysis.";
RL   Blood 85:1620-1629(1995).
RN   [5]
RP   FUNCTION.
RX   PubMed=23753625; DOI=10.1128/iai.00497-13;
RA   Fields K.A., McCormack R., de Armas L.R., Podack E.R.;
RT   "Perforin-2 restricts growth of Chlamydia trachomatis in macrophages.";
RL   Infect. Immun. 81:3045-3054(2013).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=26402460; DOI=10.7554/elife.06508;
RA   McCormack R.M., de Armas L.R., Shiratsuchi M., Fiorentino D.G.,
RA   Olsson M.L., Lichtenheld M.G., Morales A., Lyapichev K., Gonzalez L.E.,
RA   Strbo N., Sukumar N., Stojadinovic O., Plano G.V., Munson G.P.,
RA   Tomic-Canic M., Kirsner R.S., Russell D.G., Podack E.R.;
RT   "Perforin-2 is essential for intracellular defense of parenchymal cells and
RT   phagocytes against pathogenic bacteria.";
RL   Elife 4:E06508-E06508(2015).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ALTERNATIVE SPLICING, AND
RP   INDUCTION.
RX   PubMed=28705375; DOI=10.1016/j.cellimm.2017.07.001;
RA   Xiong P., Shiratsuchi M., Matsushima T., Liao J., Tanaka E., Nakashima Y.,
RA   Takayanagi R., Ogawa Y.;
RT   "Regulation of expression and trafficking of perforin-2 by LPS and TNF-
RT   alpha.";
RL   Cell. Immunol. 320:1-10(2017).
RN   [8]
RP   INVOLVEMENT IN IMD77, VARIANTS IMD77 ALA-73; 398-GLN--ALA-716 DEL AND
RP   THR-405, VARIANT SER-316, CHARACTERIZATION OF VARIANTS IMD77 ALA-73;
RP   398-GLN--ALA-716 DEL AND THR-405, CHARACTERIZATION OF VARIANT SER-316, AND
RP   FUNCTION.
RX   PubMed=28422754; DOI=10.1172/jci.insight.89635;
RA   McCormack R.M., Szymanski E.P., Hsu A.P., Perez E., Olivier K.N.,
RA   Fisher E., Goodhew E.B., Podack E.R., Holland S.M.;
RT   "MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial
RT   infections.";
RL   JCI Insight 2:0-0(2017).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=30609079; DOI=10.1111/exd.13870;
RA   Strbo N., Pastar I., Romero L., Chen V., Vujanac M., Sawaya A.P., Jozic I.,
RA   Ferreira A.D.F., Wong L.L., Head C., Stojadinovic O., Garcia D.,
RA   O'Neill K., Drakulich S., Taller S., Kirsner R.S., Tomic-Canic M.;
RT   "Single cell analyses reveal specific distribution of anti-bacterial
RT   molecule Perforin-2 in human skin and its modulation by wounding and
RT   Staphylococcus aureus infection.";
RL   Exp. Dermatol. 28:225-232(2019).
RN   [10]
RP   VARIANT IMD77 430-TYR--ALA-716 DEL, CHARACTERIZATION OF VARIANT IMD77
RP   430-TYR--ALA-716 DEL, AND FUNCTION.
RX   PubMed=33224153; DOI=10.3389/fimmu.2020.601584;
RA   Merselis L.C., Jiang S.Y., Nelson S.F., Lee H., Prabaker K.K., Baker J.L.,
RA   Munson G.P., Butte M.J.;
RT   "MPEG1/Perforin-2 Haploinsufficiency Associated Polymicrobial Skin
RT   Infections and Considerations for Interferon-gamma Therapy.";
RL   Front. Immunol. 11:601584-601584(2020).
CC   -!- FUNCTION: Plays a key role in the innate immune response following
CC       bacterial infection by inserting into the bacterial surface to form
CC       pores (By similarity). By breaching the surface of phagocytosed
CC       bacteria, allows antimicrobial effectors to enter the bacterial
CC       periplasmic space and degrade bacterial proteins such as superoxide
CC       dismutase sodC which contributes to bacterial virulence (By
CC       similarity). Shows antibacterial activity against a wide spectrum of
CC       Gram-positive, Gram-negative and acid-fast bacteria (PubMed:23753625,
CC       PubMed:26402460, PubMed:30609079, PubMed:28422754, PubMed:33224153).
CC       Reduces the viability of the intracytosolic pathogen L.monocytogenes by
CC       inhibiting acidification of the phagocytic vacuole of host cells which
CC       restricts bacterial translocation from the vacuole to the cytosol (By
CC       similarity). Required for the antibacterial activity of reactive oxygen
CC       species and nitric oxide (By similarity).
CC       {ECO:0000250|UniProtKB:A1L314, ECO:0000269|PubMed:23753625,
CC       ECO:0000269|PubMed:26402460, ECO:0000269|PubMed:28422754,
CC       ECO:0000269|PubMed:30609079, ECO:0000269|PubMed:33224153}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:28705375}; Single-pass type I membrane protein
CC       {ECO:0000255}. Note=Bacterial infection induces translocation of the
CC       cytoplasmic vesicles to bacterium-containing phagocytic vesicles and
CC       fusing of the vesicles. {ECO:0000269|PubMed:28705375}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted
CC       {ECO:0000269|PubMed:28705375}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PRF2a {ECO:0000303|PubMed:28705375};
CC         IsoId=Q2M385-1; Sequence=Displayed;
CC       Name=2; Synonyms=PRF2b {ECO:0000303|PubMed:28705375};
CC         IsoId=Q2M385-2; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Expressed constitutively in a variety of cell types
CC       including macrophages, natural killer cells, neutrophils, keratinocytes
CC       and monocytes (PubMed:26402460, PubMed:28705375, PubMed:7888681). In
CC       skin, expressed in both hematopoietic and non-hematopoietic cells with
CC       expression detected in a variety of cell types including keratinocytes,
CC       fibroblasts and endothelial cells (PubMed:30609079).
CC       {ECO:0000269|PubMed:26402460, ECO:0000269|PubMed:28705375,
CC       ECO:0000269|PubMed:30609079, ECO:0000269|PubMed:7888681}.
CC   -!- INDUCTION: By wounding; increased levels are observed in hematopoietic
CC       cells 48 hours after wounding (PubMed:30609079). Following wounding,
CC       repressed by infection with S.aureus (PubMed:30609079). Isoform 1: By
CC       lipopolysaccharide and TNF (PubMed:28705375). Isoform 2: By
CC       lipopolysaccharide and TNF (PubMed:28705375).
CC       {ECO:0000269|PubMed:28705375, ECO:0000269|PubMed:30609079}.
CC   -!- PTM: Monoubiquitinated in response to bacterial infection;
CC       ubiquitination is required for vesicular localization and antibacterial
CC       activity and can be blocked by bacterial cell cycle inhibiting factor
CC       (cif) (By similarity). {ECO:0000250|UniProtKB:A1L314}.
CC   -!- DISEASE: Immunodeficiency 77 (IMD77) [MIM:619223]: An autosomal
CC       dominant disorder characterized by recurrent, persistent bacterial and
CC       fungal infections with multiple unusual organisms. Skin and pulmonary
CC       infections are the most common. Patient macrophages show impaired
CC       killing of intracellular bacteria and organisms, including non-
CC       tubercular mycobacteria, Pseudomonas, Candida, and Aspergillus.
CC       {ECO:0000269|PubMed:28422754, ECO:0000269|PubMed:33224153}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks the C-terminal transmembrane domain.
CC       {ECO:0000269|PubMed:28705375}.
CC   -!- SIMILARITY: Belongs to the MPEG1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB84992.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK074166; BAB84992.1; ALT_INIT; mRNA.
DR   EMBL; CH471076; EAW73839.1; -; Genomic_DNA.
DR   EMBL; BC104997; AAI04998.1; -; mRNA.
DR   EMBL; BC112230; AAI12231.1; -; mRNA.
DR   CCDS; CCDS41650.1; -. [Q2M385-1]
DR   RefSeq; NP_001034485.1; NM_001039396.1. [Q2M385-1]
DR   PDB; 6U23; EM; 3.49 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=18-653.
DR   PDB; 6U2J; EM; 2.37 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=18-653.
DR   PDB; 6U2K; EM; 2.93 A; B=18-653.
DR   PDB; 6U2L; EM; 2.83 A; A/AA/B/BB/C/CC/D/DD/E/EE/F/FF/G/GG/H/HH/I/II/J/JJ/K/KK/L/LL/M/MM/N/NN/O/OO=18-653.
DR   PDB; 6U2W; EM; 3.63 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=18-653.
DR   PDBsum; 6U23; -.
DR   PDBsum; 6U2J; -.
DR   PDBsum; 6U2K; -.
DR   PDBsum; 6U2L; -.
DR   PDBsum; 6U2W; -.
DR   AlphaFoldDB; Q2M385; -.
DR   SMR; Q2M385; -.
DR   BioGRID; 128608; 3.
DR   IntAct; Q2M385; 3.
DR   STRING; 9606.ENSP00000354335; -.
DR   BindingDB; Q2M385; -.
DR   ChEMBL; CHEMBL3414409; -.
DR   TCDB; 1.C.39.14.1; the membrane attack complex/perforin (macpf) family.
DR   GlyCosmos; Q2M385; 4 sites, No reported glycans.
DR   GlyGen; Q2M385; 6 sites.
DR   iPTMnet; Q2M385; -.
DR   PhosphoSitePlus; Q2M385; -.
DR   BioMuta; MPEG1; -.
DR   DMDM; 121941470; -.
DR   jPOST; Q2M385; -.
DR   MassIVE; Q2M385; -.
DR   MaxQB; Q2M385; -.
DR   PaxDb; Q2M385; -.
DR   PeptideAtlas; Q2M385; -.
DR   ProteomicsDB; 61365; -.
DR   Antibodypedia; 21299; 97 antibodies from 21 providers.
DR   DNASU; 219972; -.
DR   Ensembl; ENST00000361050.4; ENSP00000354335.3; ENSG00000197629.6. [Q2M385-1]
DR   GeneID; 219972; -.
DR   KEGG; hsa:219972; -.
DR   MANE-Select; ENST00000361050.4; ENSP00000354335.3; NM_001039396.2; NP_001034485.1.
DR   UCSC; uc001nnu.5; human. [Q2M385-1]
DR   AGR; HGNC:29619; -.
DR   CTD; 219972; -.
DR   DisGeNET; 219972; -.
DR   GeneCards; MPEG1; -.
DR   HGNC; HGNC:29619; MPEG1.
DR   HPA; ENSG00000197629; Tissue enhanced (lymphoid).
DR   MalaCards; MPEG1; -.
DR   MIM; 610390; gene.
DR   MIM; 619223; phenotype.
DR   neXtProt; NX_Q2M385; -.
DR   OpenTargets; ENSG00000197629; -.
DR   PharmGKB; PA164723088; -.
DR   VEuPathDB; HostDB:ENSG00000197629; -.
DR   eggNOG; ENOG502QRKR; Eukaryota.
DR   GeneTree; ENSGT00390000008048; -.
DR   HOGENOM; CLU_023578_1_0_1; -.
DR   InParanoid; Q2M385; -.
DR   OMA; QTHEEGY; -.
DR   OrthoDB; 4221421at2759; -.
DR   PhylomeDB; Q2M385; -.
DR   TreeFam; TF331165; -.
DR   PathwayCommons; Q2M385; -.
DR   SignaLink; Q2M385; -.
DR   BioGRID-ORCS; 219972; 6 hits in 1135 CRISPR screens.
DR   GenomeRNAi; 219972; -.
DR   Pharos; Q2M385; Tchem.
DR   PRO; PR:Q2M385; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q2M385; protein.
DR   Bgee; ENSG00000197629; Expressed in monocyte and 158 other tissues.
DR   Genevisible; Q2M385; HS.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0045335; C:phagocytic vesicle; ISS:UniProtKB.
DR   GO; GO:0140367; P:antibacterial innate immune response; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0052337; P:disruption by host of symbiont membrane; ISS:UniProtKB.
DR   CDD; cd22579; MPEG1_P2; 1.
DR   InterPro; IPR020864; MACPF.
DR   InterPro; IPR039707; MPEG1.
DR   PANTHER; PTHR31463; MACROPHAGE-EXPRESSED GENE 1 PROTEIN; 1.
DR   PANTHER; PTHR31463:SF4; MACROPHAGE-EXPRESSED GENE 1 PROTEIN; 1.
DR   Pfam; PF01823; MACPF; 1.
DR   SMART; SM00457; MACPF; 1.
DR   PROSITE; PS51412; MACPF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Antibiotic; Antimicrobial;
KW   Cytoplasmic vesicle; Disease variant; Glycoprotein; Immunity;
KW   Innate immunity; Membrane; Reference proteome; Secreted; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..716
FT                   /note="Macrophage-expressed gene 1 protein"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000324143"
FT   TOPO_DOM        18..655
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        656..676
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        677..716
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          30..345
FT                   /note="MACPF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00745"
FT   CARBOHYD        185
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        255
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        269
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         73
FT                   /note="T -> A (in IMD77; unknown pathological significance;
FT                   decreased defense response to bacterium;
FT                   dbSNP:rs143527301)"
FT                   /evidence="ECO:0000269|PubMed:28422754"
FT                   /id="VAR_085655"
FT   VARIANT         316
FT                   /note="P -> S (decreased defense response to bacterium;
FT                   dbSNP:rs11229878)"
FT                   /evidence="ECO:0000269|PubMed:28422754"
FT                   /id="VAR_085656"
FT   VARIANT         398..716
FT                   /note="Missing (in IMD77; decreased defense response to
FT                   bacterium)"
FT                   /evidence="ECO:0000269|PubMed:28422754"
FT                   /id="VAR_085657"
FT   VARIANT         405
FT                   /note="P -> T (in IMD77; unknown pathological significance;
FT                   decreased defense response to bacterium;
FT                   dbSNP:rs200420254)"
FT                   /evidence="ECO:0000269|PubMed:28422754"
FT                   /id="VAR_085658"
FT   VARIANT         430..716
FT                   /note="Missing (in IMD77; decreased defense response to
FT                   bacterium)"
FT                   /evidence="ECO:0000269|PubMed:33224153"
FT                   /id="VAR_085659"
FT   VARIANT         467
FT                   /note="A -> T (in dbSNP:rs544864)"
FT                   /id="VAR_051200"
FT   VARIANT         552
FT                   /note="P -> L (in dbSNP:rs7926933)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051201"
FT   VARIANT         694
FT                   /note="Q -> R (in dbSNP:rs17153442)"
FT                   /id="VAR_051202"
FT   HELIX           31..38
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          57..61
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:6U23"
FT   STRAND          84..97
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          99..101
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           113..116
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            121..129
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           131..142
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          145..161
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           169..183
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           187..201
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          202..222
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           223..226
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           233..249
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:6U23"
FT   HELIX           261..269
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          270..281
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           289..294
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            295..298
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          301..309
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           310..313
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            316..318
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   HELIX           324..343
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          353..357
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          381..386
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          392..394
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            396..400
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            405..407
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          408..411
FT                   /evidence="ECO:0007829|PDB:6U2K"
FT   STRAND          416..419
FT                   /evidence="ECO:0007829|PDB:6U2K"
FT   STRAND          424..431
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          434..436
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          448..464
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          473..476
FT                   /evidence="ECO:0007829|PDB:6U2K"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:6U23"
FT   STRAND          485..487
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            490..492
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          493..496
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          502..505
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          507..509
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          511..514
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          518..520
FT                   /evidence="ECO:0007829|PDB:6U23"
FT   HELIX           521..524
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          530..532
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          539..541
FT                   /evidence="ECO:0007829|PDB:6U23"
FT   STRAND          554..556
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          562..565
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          575..578
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            582..584
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          608..614
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            615..618
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          619..622
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   TURN            625..627
FT                   /evidence="ECO:0007829|PDB:6U2J"
FT   STRAND          630..632
FT                   /evidence="ECO:0007829|PDB:6U2K"
FT   HELIX           635..645
FT                   /evidence="ECO:0007829|PDB:6U2J"
SQ   SEQUENCE   716 AA;  78587 MW;  C863E3AF2029A0AA CRC64;
     MNNFRATILF WAAAAWAKSG KPSGEMDEVG VQKCKNALKL PVLEVLPGGG WDNLRNVDMG
     RVMELTYSNC RTTEDGQYII PDEIFTIPQK QSNLEMNSEI LESWANYQSS TSYSINTELS
     LFSKVNGKFS TEFQRMKTLQ VKDQAITTRV QVRNLVYTVK INPTLELSSG FRKELLDISD
     RLENNQTRMA TYLAELLVLN YGTHVTTSVD AGAALIQEDH LRASFLQDSQ SSRSAVTASA
     GLAFQNTVNF KFEENYTSQN VLTKSYLSNR TNSRVQSIGG VPFYPGITLQ AWQQGITNHL
     VAIDRSGLPL HFFINPNMLP DLPGPLVKKV SKTVETAVKR YYTFNTYPGC TDLNSPNFNF
     QANTDDGSCE GKMTNFSFGG VYQECTQLSG NRDVLLCQKL EQKNPLTGDF SCPSGYSPVH
     LLSQIHEEGY NHLECHRKCT LLVFCKTVCE DVFQVAKAEF RAFWCVASSQ VPENSGLLFG
     GLFSSKSINP MTNAQSCPAG YFPLRLFENL KVCVSQDYEL GSRFAVPFGG FFSCTVGNPL
     VDPAISRDLG APSLKKCPGG FSQHPALISD GCQVSYCVKS GLFTGGSLPP ARLPPFTRPP
     LMSQAATNTV IVTNSENARS WIKDSQTHQW RLGEPIELRR AMNVIHGDGG GLSGGAAAGV
     TVGVTTILAV VITLAIYGTR KFKKKAYQAI EERQSLVPGT AATGDTTYQE QGQSPA
//
